Colorectal

Most recent

Predictive value of skin toxicity and panitumumab efficacy

NE Oncology Issue - June 2007 Background Skin toxicities are a common side effect with EGFR inhibitor treatment. Results from the pivotal phase III trial for cetuximab indicate that there may be a physiologic correlation between the onset of skin toxicity and...

Canadian perspective by Dr. Cripps

NE Oncology Issue - June 2007 The data from the presentations at ASCO indicate that panitumumab is certainly very similar to cetuximab with regards to the efficacy and side effects profile. Panitumumab has the added advantage of slightly lower side effects and...

Twitter feed

Already looking forward to #ASH19 ? The NE Live Team has you covered until then. Catch up on perspectives captured… https://t.co/TPVZDwe1nc
h J R
Unable to attend #ASH18 ? NE Live was on site to capture up-to-the-minute perspectives on pivitol research. Visit… https://t.co/hyGWk82vqo
h J R
Watch the NE Live team discuss The GRIFFIN Study in Patients with Newly Diagnosed Multiple Myeloma Eligible for HDT… https://t.co/bIY5TzmT9L
h J R
The NE Live team caught up with Dr. Laurie Sehn on day 2 of #ASH18 to discuss The AUGMENT Study with Lenalidomide a… https://t.co/vE7NnCBL40
h J R

Other

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Twitter feed

Already looking forward to #ASH19 ? The NE Live Team has you covered until then. Catch up on perspectives captured… https://t.co/TPVZDwe1nc
h J R
Unable to attend #ASH18 ? NE Live was on site to capture up-to-the-minute perspectives on pivitol research. Visit… https://t.co/hyGWk82vqo
h J R
Watch the NE Live team discuss The GRIFFIN Study in Patients with Newly Diagnosed Multiple Myeloma Eligible for HDT… https://t.co/bIY5TzmT9L
h J R
The NE Live team caught up with Dr. Laurie Sehn on day 2 of #ASH18 to discuss The AUGMENT Study with Lenalidomide a… https://t.co/vE7NnCBL40
h J R